Resistell News:

Resistell AG closes CHF 3.5M series A financing round

newsimage
newsimage
Resistell News:

Resistell AG closes CHF 3.5M series A financing round

Resistell AG has today closed an oversubscribed series A financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s fastest phenotypic antibiotic susceptibility test.
curves

Latest news

news image news image
3rd July 2017

Diagnostik Startup-ausgezeichnet · Resistell AG

Im Rahmen des ersten Swiss Diagnostics Start-Up Day 2017 an der Fachhochschule Nordwestschweiz präsentierten sechs Start-Ups aus der Biotechnologie und Diagnostik ihre Geschäftsideen einer Expertenjury.
news image news image
28th June 2017

Resistell was the winner of the first Swissbiolabs Challenge

Congratulations to the Winner of the first Swissbiolabs Challenge, Danuta Cichocka for her great presentation and innovative idea!
news image news image
3rd June 2017

#Resistell

It is estimated that at least 700 000 people die every year from the infections caused by antibiotic resistant bacteria. If no action is taken the death toll may reach 10 million a year by 2050. It is more than the number of people currently dying from road traffic accidents and cancer together.
news image news image
1st June 2017

#Resistell

Pictures of the Swiss Diagnostics Start-Up Day 2017! 90 participants, six startup pitches, two keynotes, five supporting organisations, an inspiring success story and a proud winner of 5’000 CHF were impressive facts of the first Swiss Diagnostics Start-up Day in Olten!
news image news image
11th May 2017

#Resistell #Swissbiolabs #SWISSBIOLABSAWARD2017

Congratulations to the Winner of the first Swissbiolabs Challenge, Danuta Cichocka for her great presentation and innovative idea!
news image news image
11th May 2017

#Resistell #Swissbiolabs #SWISSBIOLABSAWARD2017

Danuta Cichocka from the winning company Resistell is awarded the Swissbiolabs Award 2017.